CAR-T therapy is limited by off-target sequestration in liver, spleen, and lungs, which reduces tumor delivery and risks systemic toxicity. Genetic engineering approaches are complex and carry safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results